Literature DB >> 6112379

Immunosuppressive action of captopril blocked by prostaglandin synthetase inhibitor.

S A Johnsen, M Aurell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112379     DOI: 10.1016/s0140-6736(81)91777-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals.

Authors:  C Odaka; T Mizuochi
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

2.  Differential effects of captopril and enalapril, two angiotensin converting enzyme inhibitors, on immune reactivity in experimental lupus disease.

Authors:  A Tarkowski; H Carlsten; H Herlitz; G Westberg
Journal:  Agents Actions       Date:  1990-08

Review 3.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

4.  Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.

Authors:  A Fogo; Y Yoshida; A D Glick; T Homma; I Ichikawa
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

5.  Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis.

Authors:  J R Lowe; J S Dixon; J A Guthrie; P McWhinney
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

Review 6.  Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies.

Authors:  Eleonora Ruocco; Vincenzo Ruocco; Maria Lina Tornesello; Alessio Gambardella; Ronni Wolf; Franco M Buonaguro
Journal:  Clin Dermatol       Date:  2013 Jul-Aug       Impact factor: 3.541

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.